Latest Melanoma Stories
- Array to receive global rights from Novartis to innovative BRAF inhibitor - BOULDER, Colo., Jan. 23, 2015 /PRNewswire/ -- Array BioPharma Inc.
GRENOBLE, France, Jan.
NEW YORK, Jan. 12, 2015 /PRNewswire/ - Analyst report issued by Small Cap IR. Provectus Biopharmaceuticals, Inc.
MISSISSAUGA, ON, Jan. 9, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc.
LONDON, December 12, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Melanoma Drugs - new study showing you trends,
SCIB1 continues to generate highly encouraging survival data; Modi-1 vaccine on track for 2016 entry into clinic NOTTINGHAM, England, December 10, 2014 /PRNewswire/ --
Study is the First to Evaluate Investigational Combination of an Oncolytic Immunotherapy and Anti-PD-1 Therapy THOUSAND OAKS, Calif., Dec.
When humans migrated out of Africa, the pigmentation in their skin gradually adapted to cooler climates resulting in the paler skin of people who now live in higher latitudes. But natural selection is furthering this adaptive process despite an increased risk of skin cancer.
More Images (1 images) »